Conference programme
Thursday 29 January
12.00
Registration, lunch, exhibition and poster viewing
12.40
Welcome and introduction
Matt Williams and Julian Cahill
12.50
Session 1 - Novel Imaging
12.50
Could rCBV Values Prior to SRS be Used to Predict Progression Status of Brain Metastases?
Heather Rowe
13.00
​Beyond Conventional MRI: Advanced Imaging in Post-SRS Treatment Response Assessment
Markand Patel
13.15
Evaluating early changes in the post-radiosurgery vestibular schwannoma microenvironment: a multinuclear MRI study
Daniel Lewis
13.25
Optimal imaging for planning AVMs
George Tse, Sheffield ​
13.40
Discussion
13.50
Session 2 - Single session versus hypofractionation for benign targets
13.50
Cyberknife radiosurgery and hypofractionated stereotactic radiotherapy for larger vestibular schwannomas
Amy Irwin
14.00
Single - vs multi-fraction radiosurgery for Benign Targets
Natasha Chaudary
14.10
Outcomes using Cyberknife Radiosurgery and Hypofractionated Stereotactic Radiotherapy for Meningiomas (P07), Dr James Riley
Dr James Riley
14.20
Hypofractionation for benign tumours
Paul Sanghera
14.40
Session 3 - Sponsored presentations
15.00
Refreshments, exhibition and poster viewing
15.30
Session 4 - Use of PTVs and managing uncertainty in SRS
15.30
Keynote address: The Case for margins in SRS
Marcel van Herck
15.45
The case against margins in SRS
Ian Paddick ​
16.00
Discussion
16.10
Session 5 - Approaches and outcomes from SRS for brain metastases: Case reports
​​
16.10
Multi-arc non-coplanar VMAT - can extracranial dose be reduced without compromising plan quality (P03),
Esme Votta
16.20
Investigating the optimal prescription isodose for linac-based SRS
Dan Welsh​
16.30
One isocenter to treat them all: a 10 year retrospective study of SRS for Multiple Brain Metastases
Gabriella Pastore
16.40
CyberKnife Stereotactic Radiosurgery for Brainstem Metastases
Mitchell Hickman
16.55
Session 6 - AVM's
16.55
Stereotactic Radiosurgery for Persistent Paediatric AVMs: The Relevance of Previous Treatment Response on the Decision for Further Treatment, National Centre for Stereotactic Radiosurgery in Sheffield, UK,
David Eagle
17.05
Commissioning of an Arteriovenous Malformation (AVM) Service at the Bristol GammaKnife Centre
Lucy Winch
17.15
How we would treat: Discussion on the treatment of interesting clinical cases - benign
18.00
Business meeting
19.30
Dinner - Victoria and Albert Marriott Hotel
Friday 30 January
08.30
Registration, refreshments, exhibition and poster viewing
08.55
Welcome and introduction
Matt Williams and Julian Cahill
09.00
Session 7 - Systemic therapies and patterns of care
09.00
Sequencing radiosurgery with systemic therapy in melanoma brain metastases
Mark Pinkham
09.20
​Access to stereotactic radiosurgery centres across the United Kingdom – an investigation of travel time
Stephen David Robinson
09.30
Radionecrosis in brain tumours: National insights on care provision and access to bevacizumab in the United Kingdom
Dr Sarah Kingdon
09.40
adiosurgery for Brain Metastases: From Few to Many — The New Normal?
Ana Luis
09.55
Session 8 - Pituitary Adenomas
09.55
Endocrine outcomes after surgery
Professor Karim Meeran
10.15
Endocrine outcomes after SRS
Jean Regis
10.35
Discussion
10.45
Refreshments, exhibition and poster viewing
11.15
Session 9 - Sponsored presentations
11.50
Session 10 - Vestibular Schwannoma
11.50
SRS for vestibular schwannoma: Large tumours, retreatment with SRS, what are our organs at risk?
Jean Regis
12.10
Lunch, exhibition and poster veiwing
13.00
Session 11 - SRS for Functional Disorders
13.00
SRS for movement disorders
Jean Regis
13.20
Evaluation of Elements’ MRI distortion correction in radiosurgery planning
Abdul H. Mroué
13.30
Initial experience of using Cyberknife to deliver prolonged fractionation
Mitchell Hickman
13.45
Session 12 - Treatment planning and other topics
13.45
Planning a vestibular schwannoma with Gamma Knife – live demonstration
Ian Paddick
14.00
How we do it: Planning a vestibular schwannoma with the Cyberknife
Paul Sanghera and Tim Jackson
14.15
How we do it: Planning a vestibular schwannoma with a linac
Abdul H. Mroué
14.30
Discussion
14.35
Capturing quality-of-life and experience pre-SRS in patients diagnosed with brain metastases
Kerlann Le Calvez
14.45
Outcomes for Patients with Frailty Receiving SRS for Brain Metastases Catherine Fell
14.55
Cognitive Decline after Brain Radiosurgery (CoDeB-Rad) at 3 months: Cognitive and Quality of Life (QoL) data
Anna Bangiri
15.05
Hippocampal Dosimetry and Neurocognitive Function in Patients undergoing Stereotactic Radiosurgery
Sahar Iqbal
15.15
Refreshments, exhibition and poster viewing
15.30
What are the challenges and opportunities for equitable SRS access? Insights from the Tessa Jowell Brain Cancer Mission
Nicky Huskens
15.50
Update on DVLA driving restrictions post SRS
Julian Cahill
16.10
Closing remarks
Matt Williams & Julian Cahill